Profound Aminos: How to Check a Peptide Seller

By What Peptides Editorial Team · Updated 2026-09-14 · Part of Peptide Vendor Reviews: How to Judge a Supplier From Public Evidence

Names in this category often use the word aminos, and that word is worth examining before anything else. An amino acid is a single residue, while a peptide is two or more residues joined through an amide bond formed between the carboxyl carbon of one and the amine nitrogen of the next, releasing water. Oligopeptides run roughly two to twenty residues and polypeptides past that. A product described only as an amino blend and a product described as a specific peptide sequence are documented in completely different ways, and the certificate should make clear which one is being sold.

This page makes no claim about profound aminos. We have not ordered from the company, analysed any material or verified its registration, and nothing here should be read as a verdict. What follows is a checklist ordered by how much effort each item takes, starting with what anyone can see and ending with the documents that only the seller can supply.

What Public Records Show

Three public traces are worth pulling. The domain record, through the icann lookup service, gives registrar, creation date and whether registrant details are redacted. A national or state business registry, if the seller states a jurisdiction and a company number, gives the registered name, office and filing history. Public web archives show how the site and its policy pages have changed over time. Together these describe whether there is a durable, identifiable entity behind the brand, which is a precondition for everything else and nothing more than that.

The second trace is the catalogue itself. Read three or four product entries closely. Does each list a sequence, a molecular formula or mass, and a batch identifier? Is the naming consistent with the names used in the published literature for that molecule, or does the seller use an idiosyncratic abbreviation? Does the same molecule appear twice under two names, or does one name cover two different sequences? Catalogues assembled from supplier spreadsheets accumulate exactly these errors, and a vendor that fixes them when told is a different proposition from one that does not answer.

Third, contact. Send one specific written question about analytical documentation and see what comes back. A dated reply from a named person that answers the question, attaches a batch-matched certificate and identifies the laboratory is a strong signal. A template that restates marketing copy is a weak one. This takes a day and produces more usable information than most of the rest of the public record combined.

Risk Signals Worth Recording

Some signals are visible without contacting anyone. No batch or lot number anywhere in the catalogue is the most important, because a certificate without a lot to match it to is unfalsifiable. A purity figure with no method, column or wavelength is second, since the number cannot be reproduced or compared. A certificate with no date and no laboratory name is third. Prices far below the range quoted elsewhere for the same sequence and quantity are a fourth, and should be read as a prompt to request documents rather than as a bargain.

A second group of signals is structural. No published terms covering returns, replacements, delayed delivery or damaged cold-chain parcels means there is no written standard to refer to if something goes wrong. A seller limited to irreversible transfer methods removes the usual recovery route. Persistent countdown or scarcity messaging is designed to compress the checking window. These are statements about how risk is allocated between the two parties, and they are worth weighing as heavily as any analytical question.

Documents to Request, in Order of Usefulness

Ask for the batch-matched certificate first and check three things before reading any number: that the lot matches what you would receive, that the document carries a date, and that a laboratory is named. Then read the method rather than the headline. A reversed-phase HPLC result should state the column, the gradient, the detection wavelength and the integration basis; without those, the percentage is not comparable to anything. Ask whether the reported figure is purity by peak area or peptide content by mass, and if the seller does not know the difference, that is itself informative.

Identity comes next and is usually the cheapest confirmation available. Mass spectrometry should report an observed mass against a theoretical mass calculated from the sequence, and the two should agree within the tolerance expected for the ionisation method used. A sequence listing plus a molecular formula lets a reader check the arithmetic independently, since each bonded residue contributes its residue mass less the 18.02 Da of water released when the peptide bond formed. Where the material is intended for cell or tissue work, sterility and endotoxin results for that specific batch belong in the set; where it is not, their absence should be recorded rather than assumed.

Finally, handling. A specification should state a storage temperature range, an expiry or retest date, and whether the material is lyophilised or already in solution. Lyophilised peptide powders are commonly held frozen at about -20 degrees C while reconstituted solutions are refrigerated at about 2 to 8 degrees C, and repeated freeze-thaw cycles are the usual way a good sample is ruined after it arrives. how storage conditions affect peptide stability covers this in more detail than a vendor page normally will.

Nothing above is a finding about profound aminos. We have not verified a registration, tested material or spoken to the company, and the reader should run these checks rather than inherit a conclusion from us. Research peptides are generally sold labelled for research use only and not for human consumption, and the legal position depends on jurisdiction, since some sequences are prescription medicines in some countries. Check your national regulator before ordering. This page sits in our cluster on evaluating peptide sellers, and what documentation says about quality at a similarly named seller uses the same checklist from a different angle.

This page is part of the Peptide Vendor Reviews: How to Judge a Supplier From Public Evidence guide.